Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
14 oct. 2024 02h30 HE
|
INVENTIVA
Inventiva secures €94.1 million of a multi-tranche equity financing of up to €348 million, subject to satisfaction of specified conditions, from both new and existing investors, and up to $30 million...
Borvo Medical Announces U.S. FDA 510(k) Clearance for Innovative Surgical Device, Offering a Minimally Invasive Option for Surgical Brain Treatment
08 oct. 2024 08h00 HE
|
Borvo Medical
Borvo EVAC™ System Provides Advanced Approach for the Growing Number of PatientsRequiring Subdural Hematoma (SDH) Drainage Driven by Factors Such as Head Injuries and an Aging Population MOUNTAIN...
Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD)
08 oct. 2024 04h00 HE
|
Somagenetix AG
ZURICH, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Somagenetix AG, a pioneering biotech company dedicated to revolutionizing gene therapy for phagocyte disorders, announced today the initial closing of its...
Western Investment Company Announces Rights Offering
07 oct. 2024 07h30 HE
|
The Western Investment Company of Canada
The Western Investment Company launches Rights Offering for holders of record on Oct. 15, 2024 that will receive one right to purchase one common at $0.40
Insider information: Tornator Oyj considers issuance of new green notes expected to be rated Baa3 (stable) by Moody's Ratings
07 oct. 2024 04h00 HE
|
Tornator Oyj
Tornator Oyj Tornator Oyj Stock Exchange Release 7 October 2024 at 11.00 AM Insider information:...
Sisäpiiritieto: Tornator Oyj harkitsee uuden vihreän joukkovelkakirjalainan liikkeeseenlaskua, jonka oletetaan saavan luottoluokituksen Baa3 (vakaa) Moody's Ratingsilta
07 oct. 2024 04h00 HE
|
Tornator Oyj
Tornator Oyj Tornator Oyj Pörssitiedote 7.10.2024 klo 11.00 Sisäpiiritieto: Tornator Oyj harkitsee uuden vihreän joukkovelkakirjalainan liikkeeseenlaskua, jonka oletetaan saavan...
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®
03 oct. 2024 03h00 HE
|
Enara bio
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio’s EDAPT®...
Radisson annonce l’augmentation de son placement privé préalablement annoncé à 7 millions $
02 oct. 2024 06h30 HE
|
Ressources Minières Radisson Inc.
ROUYN-NORANDA, Québec, 02 oct. 2024 (GLOBE NEWSWIRE) -- Ressources minières Radisson Inc. (TSX-V : RDS, OTC : RMRDF) (« Radisson » ou la « Société ») est heureuse d’annoncer que due à la forte...
Radisson Announces Additional Upsize of Previously Announced Private Placement to $7 Million
02 oct. 2024 06h30 HE
|
Radisson Mining Resources Inc.
Radisson upsized private placement
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
01 oct. 2024 08h30 HE
|
Evoke Pharma, Inc.
Nantahala to nominate 2 board seats Portion of the proceeds received from warrants executed at $8.16/share SOLANA BEACH, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc....